Paracetamol Use During Pregnancy: New Insights on ADHD and Autism Risk
In recent discussions among health care professionals and expectant mothers, the use of paracetamol (acetaminophen) during pregnancy has often raised concerns, particularly regarding its potential links to neurodevelopmental disorders such as Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD). However, a significant longitudinal study from Hong Kong has shed new light on this topic.
Study Overview
A comprehensive cohort study conducted in Hong Kong has found no substantial correlation between paracetamol usage during pregnancy and an increased risk of ASD or ADHD in offspring. The research team led by Shan Luo utilized a sibling-controlled design, an approach that strengthens the study’s findings by controlling for unmeasured familial factors that could influence outcomes. This study was published in JAMA Internal Medicine (2026; DOI: 10.1001/jamainternmed.2026.2215).
Paracetamol: A Common Choice
Paracetamol is widely used as a first-line treatment for pain relief and fever reduction during pregnancy. Its perceived safety has made it a go-to medication for many expectant mothers. Prior observational studies have suggested a possible association between paracetamol use and a heightened risk of ASD and ADHD, leading to increased caution among healthcare providers and patients alike.
What the New Study Reveals
The findings from this recent study challenged previous assumptions. The authors noted that many of the earlier observation studies could not fully account for familial variables that may skew results. The sibling-controlled design of Luo’s study helps to mitigate this limitation, as the effects of shared genetic and environmental factors within families can be more easily isolated.
By focusing on sibling comparisons, the study provides stronger evidence against the hypothesis that paracetamol use in pregnancy directly contributes to neurodevelopmental disorders. This suggests that other unmeasured familial influences—such as genetic predisposition or environmental exposures—may be at play.
Implications for Expectant Mothers
For pregnant women, these findings offer a degree of reassurance. While it remains essential for mothers to consult healthcare providers about medication use during pregnancy, the new evidence indicates that paracetamol can be used without undue fear of significantly increasing the risk of ASD or ADHD in their children.
Conclusion: Rethinking Causation
As our understanding of the impacts of medications during pregnancy evolves, it becomes increasingly important to consider the complexities of causation. The findings from Hong Kong highlight the need for continued research, particularly studies that use robust methodologies to disentangle the effects of medications from other familial factors.
In conclusion, while the debate surrounding paracetamol use in pregnancy is ongoing, the new evidence presented in this study provides a more nuanced view. Expecting mothers can feel more secure in their choices, with the understanding that not all associations imply direct cause-and-effect relationships. As always, informed decision-making in consultation with healthcare professionals will lead to the best outcomes for both mother and child.
